Psychemedics Corporation (PMDI)
Psychemedics Corporation is a healthcare company whose common stock is listed on OTC Markets under the symbol PMDI. Through itself and its subsidiaries, the company provides hair-sample testing services for the detection of drugs of abuse and certain health markers in the United States and internationally. Its testing portfolio includes screening and confirmation services using mass spectrometry for substances such as cocaine, marijuana, PCP, amphetamines, opioids, synthetic cannabinoids, benzodiazepines, nicotine, fentanyl and fentanyl analogs, and alcohol. The company’s results can provide both quantitative information and longer-term historical indicators of drug use patterns. Psychemedics serves employers for applicant and employee screening, as well as treatment professionals, law enforcement agencies, school administrators, and parents concerned about drug use. The company was incorporated in 1986 and is headquartered in Dallas, Texas.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | Market Cap |
|---|---|---|---|---|---|---|---|
|
OTC-PMDI
|
Not available
|
Not available
|
Not available
|
Good
|
0.0%
|
November 12, 2026
|
15.263 M
|